HomeESALF • OTCMKTS
Eisai Co Ltd
Follow
Market news
Financials
Income Statement
Revenue
Net income
| (JPY) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 190.50B | -3.89% |
Operating expense | 147.67B | 9.36% |
Net income | 13.31B | -18.47% |
Net profit margin | 6.99 | -15.17% |
Earnings per share | — | — |
EBITDA | 16.70B | -51.93% |
Effective tax rate | 28.40% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 304.68B | 13.73% |
Total assets | 1.39T | 10.33% |
Total liabilities | 494.82B | 12.26% |
Total equity | 898.98B | — |
Shares outstanding | 287.04M | — |
Price to book | 0.01 | — |
Return on assets | 1.24% | — |
Return on capital | 1.62% | — |
Cash Flow
Net change in cash
| (JPY) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 13.31B | -18.47% |
Cash from operations | 18.06B | -24.73% |
Cash from investing | -2.98B | -17.40% |
Cash from financing | -9.34B | 64.66% |
Net change in cash | 19.89B | 3,150.15% |
Free cash flow | -179.75M | -101.03% |
Previous close
$42.84
Year range
$37.53 - $81.03
Market cap
12.93B USD
Avg Volume
1.40K
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
About
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Wikipedia
CEO
Founded
Dec 6, 1941
Headquarters
Website
Employees
11,076